High-Dose Acetaminophen with N-acetylcysteine Rescue Inhibits M2 Polarization of Tumor-Associated Macrophages
Cancers · 28.09.2023 · 15 (19) · 4770
DOI: 10.3390/cancers15194770 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 28.09.2023. Verfasst von Allyn Bryan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterans Affairs, Richmond, VA 23249, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NCI NIH HHS, Virginia Commonwealth University Flow Cytometry, Cancer Mouse Models and Microscopy Shared Resource.
Abstract (Originalsprache)
High-dose acetaminophen (AAP) with N-acetylcysteine (NAC) rescue is among the few treatments that has shown activity in phase I trials without achieving dose-limiting toxicity that has not progressed to evaluation in later line studies. While the anti-tumor effects of AAP/NAC appear not to be mediated by glutathione depletion and free radical injury, the mechanism of anti-tumor effects of AAP/NAC has not been definitively characterized. In vitro, the effects of AAP/NAC were evaluated on bone marrow derived macrophages. Effects of AAP on IL-4/STAT6 (M2) or IFN/LPS/STAT1 (M1) signaling and downstream gene and protein expression were studied. NAC reversed the AAP toxicity in the normal liver but did not reverse AAP cytotoxicity against tumor cells in vitro. AAP/NAC selectively inhibited IL-4-induced STAT6 phosphorylation but not IFN/LPS-induced STAT1 phosphorylation. Downstream, AAP/NAC inhibited IL-4 induction of M2-associated genes and proteins but did not inhibit the IFN/LPS induction of M1-associated genes and proteins. In vivo, AAP/NAC inhibited tumor growth in EF43.fgf4 and 4T1 triple-negative breast tumors. Flow cytometry of tumor-associated macrophages revealed that AAP/NAC selectively inhibited M2 polarization. The anti-tumor activity of high-dose AAP/NAC is lost in macrophage-depleted mouse syngeneic tumor models, suggesting a macrophage-dependent mechanism of action. In conclusion, our study is the first to show that high-dose AAP/NAC has profound effects on the tumor immune microenvironment that facilitates immune-mediated inhibition of tumor growth.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterans Affairs, Richmond, VA 23249, USA.
- Department of Veterans Affairs, Charleston, SC 29405, USA.
- Department of Anatomy and Neurobiology, Virginia Commonwealth University, Richmond, VA 23284, USA.
- Department of Pathology, Virginia Commonwealth University, Richmond, VA 23284, USA.
- Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA 23284, USA.
- Department of Hematology and Oncology, Virginia Commonwealth University, Richmond, VA 23284, USA.
ORCID-Profile: Howard Li, Won Sok Lee
Förderung
- BLRD VA
- NCI NIH HHS
- Virginia Commonwealth University Flow Cytometry, Cancer Mouse Models and Microscopy Shared Resource
- NIH-NCI Cancer Center Support
- Swim Across America grant and VA
Zitieren
APA
Bryan, A., Pingali, P., Joslyn, M., Li, H., Bernas, T., Koblinski, J., Landry, J., Lee, W. S., Patel, B., & Neuwelt, A. (2023). High-Dose Acetaminophen with N-acetylcysteine Rescue Inhibits M2 Polarization of Tumor-Associated Macrophages. Cancers, 15(19), 4770. https://doi.org/10.3390/cancers15194770
Vancouver
Bryan A, Pingali P, Joslyn M, Li H, Bernas T, Koblinski J, et al. High-Dose Acetaminophen with N-acetylcysteine Rescue Inhibits M2 Polarization of Tumor-Associated Macrophages. Cancers. 2023;15(19):4770. doi:10.3390/cancers15194770
BibTeX
@article{Bryan2023,
author = {Bryan, Allyn and Pingali, Pavani and Joslyn, Martha and Li, Howard and Bernas, Tytus and Koblinski, Jennifer and Landry, Joseph and Lee, Won Sok and Patel, Bhaumik and Neuwelt, Alexander},
title = {High-Dose Acetaminophen with N-acetylcysteine Rescue Inhibits M2 Polarization of Tumor-Associated Macrophages},
journal = {Cancers},
year = {2023},
volume = {15},
number = {19},
pages = {4770},
doi = {10.3390/cancers15194770}
}
EUVIMED